Vildosola, Cyan Scent C.
HRN: 18-19-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/09/2024
07/16/2024
INTRAVENOUS
600 Mg
Every 6 Hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes